Abstract
Hepatocellular carcinoma (HCC) is the most frequently occurring primary tumour of the liver in adults and the third most common cause of cancer-related deaths in the world. The incidence of HCC is increasing both in Europe and in the United States due to the increasing prevalence of hepatitis C. Of recognised importance, when making decisions regarding the most appropriate management of a patient with HCC, is the involvement of a multidisciplinary team of hepatologists, hepatobiliary surgeons, a liver transplant team, interventional radiologists, and medical and radiation oncologists. This manuscript reviews the role of stereotactic body radiotherapy in HCC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
